Joint Disease News
-
How to deal with the trend of population aging to achieve a sustainable future
The World Social Report 2023 calls for concrete measures to support an aging global population in the face of rising pension and health care costs. According to a study published by the United Nations Department of Economic and Social Affairs, population aging is the defining global trend of our time. Countries can benefit by promoting equality of opportunity from birth, so that everyone has the ...
-
Caira Surgical to Participate in Upcoming Investor Conferences
Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA '23 partnering event. March 7 – CG 2023 Musculoskeletal ...
-
THINK Surgical Announces Collaboration with Definition Health
(FREMONT, CA) December 5, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced a collaboration with UK based digital health company, Definition Health. The companies will jointly develop a seamless, web-based, connected care solution to enhance the surgical planning experience for surgeons using THINK’s robotic technologies for joint ...
-
Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
Orginally published by https://www.globenewswire.com/ Emergent BioSolutions Inc. (NYSE:EBS) announced today a research award by the U.S. Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) to evaluate efficacy of the company’s single-dose chikungunya virus virus-like particle (CHIKV VLP) vaccine candidate. Emergent will begin the planning phase, the first ...
-
THINK Surgical Raises $100 Million to Accelerate Commercialization of Robotic Surgery Products
(FREMONT, CA) October 26, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots today announced that KDB Investment Global Healthcare of Korea, a new investor, has invested $100M in the company to enable a faster commercial launch of several new products. This investment will allow THINK Surgical to bring new products to market which will offer a common ...
-
VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough
VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced it has been selected as the winner of the “Predictive Analytics Solution of the Year" in the BioTech Breakthrough Awards program conducted by BioTech Breakthrough. Biotech Breakthrough is a leading independent ...
By VeriSIM Life
-
Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant
Dr. Scott A. Hacker, an expert in arthroscopic surgery, total joint replacements, sports medicine and fracture care, and Active Implants, a company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in San Diego has been performed. Dr. Hacker is the only physician in San Diego County – and Grossmont Orthopedic Medical Group is one of ...
-
Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant
Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration. The NUsurface® Meniscus Implant is the first “artificial meniscus” to be marketed in Europe and, if cleared by the FDA, would be the first ...
-
What to Expect for an Epidural Injection
Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. Many are forced to miss days of work due to injury. With rising healthcare costs, many back pain sufferers think that they are left without a real solution, until they try epidural injections. An epidural injection is the infusion of ...
-
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported regrowth. These results were presented at the recent Swiss Society for Microbiology (SSM) Annual Congress 2022 in Lausanne, Switzerland. ...
-
Alnylam Receives Approval in Europe for AMVUTTRA® (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy
– AMVUTTRA Demonstrated Halting or Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – Decision Follows Positive Opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in July 2022 – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 20, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), ...
-
THINK Surgical and Curexo Announce Entry Into Development and Distribution Agreement
(FREMONT, CA) August 1, 2022 – THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea. THINK and Curexo have a strong working relationship based on historical development collaboration and Curexo distributes ...
-
Think Surgical Appoints Park Mehendale as Vice President of Operations
(FREMONT, CA) July 26, 2022?- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Parikshit (Park) Mehendale as vice president of operations. Mr. Mehendale brings nearly 20 years of global operations, supply chain, and engineering management experience to the THINK organization. At THINK, Mr. Mehendale will lead supply chain, ...
-
Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that ...
By Robocath
-
Chris Fronk Promoted to Chief Commercial Officer of THINK Surgical
(FREMONT, CA) July 14, 2022 – THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Chris Fronk as the Chief Commercial Officer. Mr. Fronk joined THINK Surgical in January 2022 as VP Sales and has added tremendous value to the company in a short period of time. Based on his nearly two decades of experience in selling enabling ...
-
Acumed Acquires Exsomed to Enhance Its Portfolio of Upper Extremity Solutions
Acumed, a Colson Medical - Marmon - Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries. Acumed, a Colson ...
-
VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs
VeriSIM Life (VeriSIM) www.verisimlife.com, a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for breakthrough drug development, today announced that it has entered into a collaboration with Mayo Clinic to improve the preclinical translation of promising drug candidates. “We are excited to expand our common mission and work with ...
By VeriSIM Life
-
What Are D-Glucosamines?
Glucosamine is a natural component of cartilage and is widely used as an over-the-counter nutritional supplement to reduce the pain and cartilage loss of osteoarthritis. Glucosamine is usually taken in combination with chondroitin, which is a glycosaminoglycan that also exists in cartilage.Glucosamine is an amino sugar and an important molecule in the biochemical pathway of glycosylated protein ...
-
Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical
THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce that Stefan Kreuzer, M.D.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. Dr. Kreuzer has performed nearly 90 procedures** with the ...
-
BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome
BRIM Biotechnology, Inc. (“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”) the world’s leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you